PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me

All GLP-1 drugs at a glance

DrugFormApproved forMaker self-payCheapest program
ZepboundtirzepatideInjectionWeight loss, and sleep apnea with obesity$299a month at 2.5 mg, $399 at 5 mg, $449 at 7.5 to 15 mg$348/mo5 programs
MounjarotirzepatideInjectionType 2 diabetes (not approved for weight loss)$499a month, self-pay through LillyDirectNone listedno partner sells it
WegovysemaglutideInjectionWeight loss, and heart risk reduction$199a month for new patients' first two fills, then $349$278/mo4 programs
Wegovy pillsemaglutideDaily tabletWeight loss, and heart risk reduction$149a month at the 1.5 mg starting dose$208/mo2 programs
OzempicsemaglutideInjectionType 2 diabetes (not approved for weight loss)$149a month for the tablets at 1.5 mg ($199 at 4 mg, $299 at 9 mg); pens $199 for the first two fills, then $349 to $499$408/mo5 programs
FoundayoorforglipronDaily tabletWeight loss$149a month at the 0.8 mg starting dose$208/mo2 programs
RybelsussemaglutideDaily tabletType 2 diabetesNot publishedNovoCare's self-pay pharmacy does not list itNone listedno partner sells it
Compounded semaglutideSemaglutideInjection (vial)Not FDA-approvedNo makermade by compounding pharmacies, sold through telehealth programs$41/mo24 programs
Compounded tirzepatideTirzepatideInjection (vial)Not FDA-approvedNo makermade by compounding pharmacies, sold through telehealth programs$71/mo22 programs

Two molecules carry most of this table. Semaglutide is Wegovy, Ozempic and Rybelsus; tirzepatide is Zepbound and Mounjaro. Foundayo is orforglipron, a third. The diabetes brands (Ozempic, Mounjaro, Rybelsus) and the weight brands (Wegovy, Zepbound, Foundayo) differ in approval and in what insurance will pay for, not always in the molecule. Program prices are all-in monthly, membership fees included; compounded drugs are not FDA-approved. See tirzepatide vs semaglutide and every GLP-1 pill.

One price tracker per drug